Turning Point Therapeutics, Inc. Research and Development Expenses 2019-2022 | TPTX
Turning Point Therapeutics, Inc. research and development expenses from 2019 to 2022. Research and development expenses can be defined as an expense arising from studies and product development processes.
| Turning Point Therapeutics, Inc. Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2021 | $193 |
| 2020 | $113 |
| 2019 | $58 |
| 2018 | $21 |
| 2017 | $15 |
| Turning Point Therapeutics, Inc. Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2022-06-30 | $87 |
| 2022-03-31 | $55 |
| 2021-12-31 | $58 |
| 2021-09-30 | $49 |
| 2021-06-30 | $45 |
| 2021-03-31 | $41 |
| 2020-12-31 | $34 |
| 2020-09-30 | $32 |
| 2020-06-30 | $24 |
| 2020-03-31 | $23 |
| 2019-12-31 | $17 |
| 2019-09-30 | $17 |
| 2019-06-30 | $14 |
| 2019-03-31 | $10 |
| 2018-12-31 | $7 |
| 2018-09-30 | $5 |
| 2018-06-30 | $4 |
| 2018-03-31 | $4 |
